Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1801 AL 1815

Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19

Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM.

Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369.

Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease

Dhiman A, Handa M, Ruwali M, Singh DP, Kesharwani P, Shukla R.

Mitochondrion. 2022 May;64:112-124. doi: 10.1016/j.mito.2022.03.006. Epub 2022 Mar 31.

Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease

Fang X, Zhang J, Zhao J, Wang L.

J Healthc Eng. 2022 Mar 25;2022:9148650. doi: 10.1155/2022/9148650. eCollection 2022.

Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review

Azam MS, Wahiduzzaman M, Reyad-Ul-Ferdous M, Islam MN, Roy M.

Pharm Res. 2022 Apr;39(4):611-629. doi: 10.1007/s11095-022-03237-7. Epub 2022 Apr 4.

Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease

Villegas C, Perez R, Petiz LL, Glaser T, Ulrich H, Paz C.

IUBMB Life. 2022 Aug;74(8):763-779. doi: 10.1002/iub.2613. Epub 2022 Apr 5.

γ-Secretase in Alzheimer's disease

Hur JY.

Exp Mol Med. 2022 Apr;54(4):433-446. doi: 10.1038/s12276-022-00754-8. Epub 2022 Apr 8.

Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease

Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V.

Bioorg Med Chem. 2022 May 1;61:116742. doi: 10.1016/j.bmc.2022.116742. Epub 2022 Apr 5.

Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's disease

Waller ES, Yardeny BJ, Fong WY, Gan XY, Jimenez SV, Pan Y, Abasszade JH, Nicolazzo JA.

Adv Drug Deliv Rev. 2022 Jun;185:114282. doi: 10.1016/j.addr.2022.114282. Epub 2022 Apr 11.

Role of aluminum exposure on Alzheimer's disease and related glycogen synthase kinase pathway

Sanajou S, Erkekoğlu P, Şahin G, Baydar T.

Drug Chem Toxicol. 2023 May;46(3):510-522. doi: 10.1080/01480545.2022.2065291. Epub 2022 Apr 21.

The synapse as a treatment avenue for Alzheimer's Disease

Peng L, Bestard-Lorigados I, Song W.

Mol Psychiatry. 2022 Jul;27(7):2940-2949. doi: 10.1038/s41380-022-01565-z. Epub 2022 Apr 20.

Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore

Botelho MJ, Milinovic J, Bandarra NM, Vale C.

Mar Drugs. 2022 Apr 2;20(4):253. doi: 10.3390/md20040253.

The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials

Tseng PT, Zeng BY, Chen YW, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Carvalho AF, Stubbs B, Matsuoka YJ, Li DJ, Liang CS, Hsu CW, Sun CK, Cheng YS, Yeh PY, Shiue YL.

Curr Neuropharmacol. 2022;20(10):1816-1833. doi: 10.2174/1570159X20666220420122322.

Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs

Fagone P, Mangano K, Martino G, Quattropani MC, Pennisi M, Bella R, Fisicaro F, Nicoletti F, Petralia MC.

Genes (Basel). 2022 Apr 15;13(4):703. doi: 10.3390/genes13040703.

Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer's Disease

Ilina A, Khavinson V, Linkova N, Petukhov M.

Int J Mol Sci. 2022 Apr 12;23(8):4259. doi: 10.3390/ijms23084259.

Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis

Veroniki AA, Ashoor HM, Rios P, Seitidis G, Stewart L, Clarke M, Tudur-Smith C, Mavridis D, Hemmelgarn BR, Holroyd-Leduc J, Straus SE, Tricco AC.

BMJ Open. 2022 Apr 26;12(4):e053012. doi: 10.1136/bmjopen-2021-053012.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias